Pharma Industry News

Regeneron ties spike in Eylea side effect to syringes in some kits in the U.S.

Written by David Miller

Regeneron tore its manufacturing processes and supply chain apart in an investigation after a spike in a rare side effect was discovered with some patients taking its top-selling sight drug Eylea. While the company says it has found no issues with the drug or its manufacturing, it has found an association between the problem and some Becton Dickinson syringes that were distributed in the U.S.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]